Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvant

By Desombere I.   Van der Wielen M.   Van Damme P.   Stoffel M.   De Clercq N.   Goilav C.   Leroux-Roels G.  

Vaccine, Vol. 20, Iss. 19, 2002-06 ,pp. : 2597-2602

Elsevier

Access to resources Recommend Favorite

Ad hoc survey of hepatitis B vaccination campaign in newborns of HBsAg positive mothers and in 12-year-old subjects in southern Italy

By Adamo B.   Stroffolini T.   Sagliocca L.   Simonetti A.   Iadanza F.   Fossi E.   Tancredi F.   Mele A.  

Vaccine, Vol. 16, Iss. 8, 1998-05 ,pp. : 775-777

Elsevier

Access to resources Recommend Favorite

Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA

By Mollenkopf H.-J.   Groine-Triebkorn D.   Andersen P.   Hess J.   Kaufmann S.H.E.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 4028-4035

Elsevier

Access to resources Recommend Favorite

Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans

By Mao J.S.   Chai S.A.   Xie R.Y.   Chen N.L.   Jiang Q.   Zhu X.Z.   Zhang S.Y.   Huang H.Y.   Mao H.W.   Bao X.N.   Liu C.J.  

Vaccine, Vol. 15, Iss. 9, 1997-06 ,pp. : 944-947

Elsevier

Access to resources Recommend Favorite

Immunogenicity of Hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life

By Freitas da Motta M.S.   Mussi-Pinhata M.M.   Jorge S.M.   Tachibana Yoshida C.F.   Sandoval de Souza C.B.  

Vaccine, Vol. 20, Iss. 11, 2002-02 ,pp. : 1557-1562

Elsevier

Access to resources Recommend Favorite